Morbidity of hepatic resection for intermediate and advanced hepatocellular carcinoma

详细信息    查看全文

• 作者：Philipp Renner ; Jürgen Schuhbaum ; Alexander Kroemer…
• 关键词：Hepatocellular carcinoma ; BCLC ; Liver resection ; Liver cancer ; Portal hypertension
• 刊名：Langenbeck's Archives of Surgery
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：401
• 期：1
• 页码：43-53
• 全文大小：1,172 KB
• 参考文献：1.Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020–1022. doi:10.​1002/​hep.​24199 CrossRef PubMed PubMedCentral
  2.Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42(5):1208–1236. doi:10.​1002/​hep.​20933 CrossRef PubMed
  3.Verslype C, Rosmorduc O, Rougier P, Group EGW (2012) Hepatocellular carcinoma: ESMO-ESDO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii41–vii48. doi:10.​1093/​annonc/​mds225 CrossRef PubMed
  4.Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362(9399):1907–1917. doi:10.​1016/​s0140-6736(03)14964-1 CrossRef PubMed
  5.Henderson JM, Sherman M, Tavill A, Abecassis M, Chejfec G, Gramlich T (2003) AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement. HPB (Oxford) 5(4):243–250. doi:10.​1080/​1365182031001583​3
  6.Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Horbelt R, Kroemer A, Loss M, Rummele P, Scherer MN, Padberg W, Konigsrainer A, Lang H, Obed A, Schlitt HJ (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255(3):405–414. doi:10.​1097/​SLA.​0b013e31824856f5​ CrossRef PubMed
  7.Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, Lam CM, Wong J (2001) Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 234(1):63–70CrossRef PubMed PubMedCentral
  8.Earl TM, Chapman WC (2013) Hepatocellular carcinoma: resection versus transplantation. Semin Liver Dis 33(3):282–292. doi:10.​1055/​s-0033-1351783 CrossRef PubMed
  9.Thomas MB, Zhu AX (2005) Hepatocellular carcinoma: the need for progress. J Clin Oncol 23(13):2892–2899. doi:10.​1200/​JCO.​2005.​03.​196 CrossRef PubMed
  10.El-Serag HB, Marrero JA, Rudolph L, Reddy KR (2008) Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 134(6):1752–1763. doi:10.​1053/​j.​gastro.​2008.​02.​090 CrossRef PubMed
  11.Jarnagin W, Chapman WC, Curley S, D’Angelica M, Rosen C, Dixon E, Nagorney D, American Hepato-Pancreato-Biliary A, Society of Surgical O, Society for Surgery of the Alimentary T (2010) Surgical treatment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) 12(5):302–310. doi:10.​1111/​j.​1477-2574.​2010.​00182.​x CrossRef
  12.Vauthey JN, Dixon E, Abdalla EK, Helton WS, Pawlik TM, Taouli B, Brouquet A, Adams RB, American Hepato-Pancreato-Biliary A, Society of Surgical O, Society for Surgery of the Alimentary T (2010) Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) 12(5):289–299. doi:10.​1111/​j.​1477-2574.​2010.​00181.​x CrossRef
  13.Yamakado K, Kudo M (2014) Treatment strategies of intermediate-stage hepatocellular carcinomas in Japan (Barcelona Clinic Liver Cancer stage B). Oncology 87(Suppl 1):78–81. doi:10.​1159/​000368149 CrossRef PubMed
  14.European Association For The Study Of The L, European Organisation For R, Treatment Of C (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56(4):908–943. doi:10.​1016/​j.​jhep.​2011.​12.​001 CrossRef
  15.Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRef PubMed PubMedCentral
  16.Wong TC, Lo CM (2013) Resection strategies for hepatocellular carcinoma. Semin Liver Dis 33(3):273–281. doi:10.​1055/​s-0033-1351782 CrossRef PubMed
  17.Sangiovanni A, Manini MA, Iavarone M, Romeo R, Forzenigo LV, Fraquelli M, Massironi S, Della Corte C, Ronchi G, Rumi MG, Biondetti P, Colombo M (2010) The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut 59(5):638–644. doi:10.​1136/​gut.​2009.​187286 CrossRef PubMed
  18.Willatt JM, Hussain HK, Adusumilli S, Marrero JA (2008) MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 247(2):311–330. doi:10.​1148/​radiol.​2472061331 CrossRef PubMed
  19.Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, Curley SA, Ellis LM, Regimbeau JM, Rashid A, Cleary KR, Nagorney DM (2002) Simplified staging for hepatocellular carcinoma. J Clin Oncol 20(6):1527–1536CrossRef PubMed
  20.Torzilli G, Belghiti J, Kokudo N, Takayama T, Capussotti L, Nuzzo G, Vauthey JN, Choti MA, De Santibanes E, Donadon M, Morenghi E, Makuuchi M (2013) A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group. Ann Surg 257(5):929–937. doi:10.​1097/​SLA.​0b013e31828329b8​ CrossRef PubMed
  21.Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J (2002) Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg 236(5):602–611. doi:10.​1097/​01.​SLA.​0000033038.​38956.​5E CrossRef PubMed PubMedCentral
  22.Vitale A, Burra P, Frigo AC, Trevisani F, Farinati F, Spolverato G, Volk M, Giannini EG, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Cabibbo G, Felder M, Gasbarrini A, Sacco R, Foschi FG, Missale G, Morisco F, Svegliati Baroni G, Virdone R, Cillo U, Italian Liver Cancer Group (2015) Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. J Hepatol 62(3):617–624. doi:10.​1016/​j.​jhep.​2014.​10.​037 CrossRef PubMed
  23.Farinati F, Vanin V, Giacomin A, Pozzan C, Cillo U, Vitale A, Di Nolfo AM, Del Poggio P, Benvegnu L, Rapaccini G, Zoli M, Borzio F, Giannini EG, Caturelli E, Trevisani F, Italian Liver Cancer Group (2015) BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. Liver Int 35(1):223–231. doi:10.​1111/​liv.​12649 CrossRef PubMed
  24.Berzigotti A, Seijo S, Reverter E, Bosch J (2013) Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol 7(2):141–155. doi:10.​1586/​egh.​12.​83 CrossRef PubMed
  25.Colombo M, Raoul JL, Lencioni R, Galle PR, Zucman-Rossi J, Banares R, Seehofer D, Neuhaus P, Johnson P (2013) Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective. Eur J Gastroenterol Hepatol 25(6):639–651. doi:10.​1097/​MEG.​0b013e32835e33bb​ CrossRef PubMed
  26.Stockmann M, Lock JF, Malinowski M, Niehues SM, Seehofer D, Neuhaus P (2010) The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB (Oxford) 12(2):139–146. doi:10.​1111/​j.​1477-2574.​2009.​00151.​x CrossRef
  27.Seyama Y, Kokudo N (2009) Assessment of liver function for safe hepatic resection. Hepatol Res 39(2):107–116. doi:10.​1111/​j.​1872-034X.​2008.​00441.​x CrossRef PubMed
  28.Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK, AWMF) (2013) Diagnostik und Therapie des hepatozellulären Karzinoms, Langversion 1.0, AWMF Registrierungsnummer: 032-053OL.
  29.Liu PH, Hsia CY, Lee YH, Hsu CY, Huang YH, Su CW, Lee RC, Lin HC, Huo TI (2015) Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma. J Surg Oncol 111(4):404–409. doi:10.​1002/​jso.​23854 CrossRef PubMed
  
• 作者单位：Philipp Renner (1)
  Jürgen Schuhbaum (1)
  Alexander Kroemer (1)
  Florian Zeman (2)
  Martin Loss (1)
  Sven A. Lang (1)
  Edward K. Geissler (1)
  Hans J. Schlitt (1)
  Stefan A. Farkas (1)
  
  1. Department of Surgery, University Medical Center Regensburg, 93042, Regensburg, Germany
  2. Center for Clinical Studies, University Medical Center Regensburg, Regensburg, Germany
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  General Surgery
  Abdominal Surgery
  Cardiac Surgery
  Thoracic Surgery
  Traumatic Surgery
  Vascular Surgery
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1435-2451

文摘

Purpose According to current treatment guidelines, surgical resection of hepatocellular carcinoma (HCC) is mostly restricted to a limited subgroup of patients. Due to improved surgical techniques and perioperative management, liver resections may also be performed more extendedly and also in cirrhotic livers with clinical signs of portal hypertension in selected patients. In this study, the clinical and long-term outcomes of liver resection in HCC patients with or without liver cirrhosis were evaluated.